Literature DB >> 29274966

Fetuin-A: A negative acute-phase protein linked to adipose tissue function in periparturient dairy cows.

Clarissa Strieder-Barboza1, Jonas de Souza2, William Raphael1, Adam L Lock2, G Andres Contreras3.   

Abstract

Fetuin-A (FetA) is a free fatty acid transporter and an acute-phase protein that enhances cellular lipid uptake and lipogenesis. In nonruminants, FetA is involved in lipid-induced inflammation. Despite FetA importance in lipid metabolism and inflammation, its expression and dynamics in adipose tissue (AT) of dairy cows are unknown. The objectives of this study were to (1) determine serum and AT FetA dynamics over the periparturient period and in mid-lactation cows in negative energy balance (NEB) after a feed restriction protocol and (2) characterize how an inflammatory challenge affects adipocyte FetA expression. Blood and subcutaneous AT were collected from 16 cows with high (≥3.75, n = 8) or moderate (≤3.5, n = 8) body condition score (BCS) at -26 ± 7 d (far off) and -8 ± 5 d (close up) before calving and at 10 ± 2 d after parturition (early lactation) and from 14 nonpregnant mid-lactation cows (>220 d in milk) after a feed restriction protocol. Serum FetA concentrations were 0.89 ± 0.13 mg/mL at far off, 0.96 ± 0.13 mg/mL at close up, and 0.77 ± 0.13 mg/mL at early lactation and were 1.09 ± 0.09 and 1.17 ± 0.09 mg/mL in feed-restricted and control cows, respectively. Serum and AT FetA contents decreased at the onset of lactation when lipolysis was higher. No changes in AT and serum FetA were observed after feed restriction induced NEB in mid-lactation cows. Prepartum BCS had no effect on serum FetA, but AT expression of AHSG, the gene encoding FetA, was reduced in periparturient cows with high BCS at dry-off throughout all time points. Circulating FetA was positively associated with serum albumin and calcium and with BCS variation over the periparturient period. The dynamics of AHSG expression were analogous to the patterns of lipogenic markers ABDH5, ELOVL6, FABP4, FASN, PPARγ, and SCD1. Expression of AHSG and FetA protein in AT was inversely correlated with AT proinflammatory markers CD68, CD44, SPP1, and CCL2. In vitro, bovine adipocytes challenged with lipopolysaccharide downregulated FetA protein expression. Adipocytes treated with FetA had lower CCL2 expression compared with those exposed to lipopolysaccharide. Overall, FetA is a systemic and local AT negative acute-phase protein linked to AT function in periparturient cows. Furthermore, FetA may support physiological adaptations to NEB in periparturient cows.
Copyright © 2018 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  adipose tissue; biomarker; inflammation; lipolysis; transition cow

Mesh:

Substances:

Year:  2017        PMID: 29274966     DOI: 10.3168/jds.2017-13644

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  3 in total

1.  The contribution of hormone sensitive lipase to adipose tissue lipolysis and its regulation by insulin in periparturient dairy cows.

Authors:  Jenne De Koster; Rahul K Nelli; Clarissa Strieder-Barboza; Jonas de Souza; Adam L Lock; G Andres Contreras
Journal:  Sci Rep       Date:  2018-09-06       Impact factor: 4.379

2.  Transcriptomic profiling of adipose tissue inflammation, remodeling, and lipid metabolism in periparturient dairy cows (Bos taurus).

Authors:  David Salcedo-Tacuma; Jair Parales-Giron; Crystal Prom; Miguel Chirivi; Juliana Laguna; Adam L Lock; G Andres Contreras
Journal:  BMC Genomics       Date:  2020-11-23       Impact factor: 3.969

3.  Plasma proteomics reveals crosstalk between lipid metabolism and immunity in dairy cows receiving essential fatty acids and conjugated linoleic acid.

Authors:  Arash Veshkini; Harald M Hammon; Laura Vogel; Didier Viala; Mylène Delosière; Arnulf Tröscher; Sébastien Déjean; Fabrizio Ceciliani; Helga Sauerwein; Muriel Bonnet
Journal:  Sci Rep       Date:  2022-04-05       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.